The resolution designates the last Tuesday of April as APOL1-Mediated Kidney Disease (AMKD) Awareness Day in Alabama, aiming to raise awareness about this specific type of kidney disease and encourage research for improved treatments and potential cures. It highlights the genetic factors, particularly variants in the APOL1 gene, that significantly increase the risk of kidney disease among individuals of Western and Central African ancestry. The resolution emphasizes the disproportionate impact of kidney disease on African Americans, who represent a significant percentage of kidney failure cases in the United States.

Furthermore, the resolution calls for increased public awareness and education regarding AMKD, particularly for those at risk, to promote early diagnosis and management of the disease. It encourages individuals with APOL1 genetic variants to engage in regular medical consultations and adopt healthy lifestyle choices to mitigate their risk of kidney failure. The resolution also notes the absence of approved treatments targeting the underlying causes of APOL1-mediated kidney disease, while expressing hope that ongoing clinical trials may lead to effective therapies in the future.